CHARMANT, INC. – Trademark Portfolio
Entity Type: 03
CHARMANT, INC. holds 33 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 28 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 5 Nice Classification classes. Currently, 6 trademarks are registered and 1 is pending. Notable registered marks include ARISTAR, CHARMANT, I MOTION, MINAMOTO, and CHRISTIAN ROTH. The owner is based in SABAE SHI, FUKUI-KEN.
6-5, KAWASARI-CHO
SABAE SHI, FUKUI-KEN , JP
Showing of trademarks Trademarks
Trademark Classifications
CHARMANT, INC.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does CHARMANT, INC. have?
CHARMANT, INC. has 33 U.S. trademarks filed with the USPTO. Of these, 6 registered, 1 pending, 5 abandoned, 18 cancelled.
What trademark classes does CHARMANT, INC. file in?
CHARMANT, INC. files trademarks across 5 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 25 (Clothing), Class 42 (Computer & Scientific), Class 14 (Jewelry). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are CHARMANT, INC.'s most well-known trademarks?
CHARMANT, INC.'s registered trademark portfolio includes well-known marks such as ARISTAR, CHARMANT, I MOTION, MINAMOTO, and CHRISTIAN ROTH. These are among 6 currently registered trademarks in the portfolio.
What is CHARMANT, INC.'s trademark registration success rate?
CHARMANT, INC. has a 21% trademark registration rate, with 6 out of 29 resolved applications resulting in successful registration. Currently, 1 application is pending review.